Back to top
more

Glaukos (GKOS)

(Delayed Data from NYSE)

$122.77 USD

122.77
526,287

+2.04 (1.69%)

Updated Jul 22, 2024 04:00 PM ET

After-Market: $122.76 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 43% (143 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for GKOS

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Glaukos Corporation falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 295 353 414 404 174
Receivables 40 36 33 36 38
Notes Receivable 0 0 0 0 0
Inventories 42 38 23 16 43
Other Current Assets 18 17 16 13 8
Total Current Assets 395 444 486 469 263
Net Property & Equipment 103 94 69 24 22
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 349 374 399 424 449
Deposits & Other Assets 21 18 19 17 15
Total Assets 940 1,002 1,050 1,006 818
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 13 14 7 4 6
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 61 58 56 45 52
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 74 72 63 50 58
Mortgages 0 0 0 0 0
Deferred Taxes/Income 7 7 7 11 10
Convertible Debt 283 281 280 189 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 71 72 73 61 58
Other Non-Current Liabilities 14 10 9 7 5
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 479 472 463 338 145
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 1,060 997 952 977 862
Retained Earnings -599 -464 -365 -310 -190
Other Equity 1 -3 0 1 1
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 462 530 587 667 673
Total Liabilities & Shareholder's Equity 940 1,002 1,050 1,006 818
Total Common Equity 462 530 587 667 673
Shares Outstanding 48.80 47.70 46.80 44.90 36.40
Book Value Per Share 9.46 11.11 12.55 14.87 18.50

Fiscal Year End for Glaukos Corporation falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents -99,999 273 295 301 304
Receivables NA 47 40 39 39
Notes Receivable NA 0 0 0 0
Inventories NA 50 42 40 39
Other Current Assets NA 19 18 20 19
Total Current Assets NA 389 395 400 401
Net Property & Equipment NA 102 103 103 103
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 348 349 355 362
Deposits & Other Assets NA 25 21 19 18
Total Assets NA 933 940 949 957
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 13 13 10 9
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 59 61 57 55
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 72 74 67 64
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 7 7 7 7
Convertible Debt NA 283 283 282 282
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 70 71 71 71
Other Non-Current Liabilities NA 14 13 13
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 483 479 471 468
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 1,089 1,060 1,039 1,021
Retained Earnings NA -640 -599 -562 -532
Other Equity NA 1 1 1 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 451 462 478 489
Total Liabilities & Shareholder's Equity NA 933 940 949 957
Total Common Equity 0 451 462 478 489
Shares Outstanding 50.30 50.10 48.80 48.80 48.20
Book Value Per Share 0.00 9.00 9.46 9.79 10.14